Investment Advisory Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$724K Buy
2,057
+4
+0.2% +$1.43K 0.18% 92
2025
Q4
$672K Sell
2,053
-5
-0.2% -$1.59K 0.17% 95
2025
Q3
$581K Hold
2,058
0.16% 98
2025
Q2
$575K Sell
2,058
-8
-0.4% -$2.27K 0.17% 94
2025
Q1
$644K Buy
2,066
+25
+1% +$7.38K 0.22% 88
2024
Q4
$532K Sell
2,041
-19
-0.9% -$5.64K 0.18% 94
2024
Q3
$664K Buy
2,060
+19
+0.9% +$6.21K 0.23% 83
2024
Q2
$638K Buy
2,041
+1
+0% +$294 0.25% 78
2024
Q1
$580K Buy
2,040
+3
+0.1% +$878 0.24% 79
2023
Q4
$587K Sell
2,037
-1
-0% -$272 0.27% 71
2023
Q3
$548K Buy
2,038
+18
+0.9% +$4.49K 0.28% 69
2023
Q2
$448K Hold
2,020
0.23% 78
2023
Q1
$488K Sell
2,020
-16
-0.8% -$3.93K 0.28% 74
2022
Q4
$535K Hold
2,036
0.33% 63
2022
Q3
$459K Hold
2,036
0.32% 65
2022
Q2
$494K Hold
2,036
0.34% 62
2022
Q1
$492K Hold
2,036
0.3% 70
2021
Q4
$466K Buy
+2,036
New +$430K 0.3% 67

Other funds holding AMGN

Investment Advisory Group's AMGN Position: Q1 2026 in Review

Investment Advisory Group increased its Amgen (AMGN) stake by 0.19% in Q1 2026, buying an estimated $1.43K and bringing the position to 2,057 shares worth $724K. The position accounts for 0.18% of the portfolio, ranked #92.

Investment Advisory Group first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Investment Advisory Group held 2,057 shares of Amgen worth $724K as of Q1 2026.
  • Investment Advisory Group bought 4 Amgen shares in Q1 2026, an estimated $1.43K.
  • Amgen made up 0.18% of Investment Advisory Group's portfolio in Q1 2026, its #92 holding.
  • Investment Advisory Group first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Investment Advisory Group's 13F filing for Q1 2026, filed 22 Apr 2026.